Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. (Q40272095)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 June 2006

Language	Label	Description	Also known as
English	Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1.	scientific article published on 5 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. (English)

1 reference

Europe PubMed Central

19 September 2017

human parainfluenza

1 reference

based on heuristic

inferred from title

William Van Cleve

object named as

William Van Cleve

1

0 references

Brian R. Murphy

7

object named as

Brian R Murphy

1 reference

Europe PubMed Central

19 September 2017

author name string

Emerito Amaro-Carambot

2

1 reference

Europe PubMed Central

19 September 2017

Sonja R Surman

3

1 reference

Europe PubMed Central

19 September 2017

Joseph Bekisz

4

1 reference

Europe PubMed Central

19 September 2017

Peter L Collins

5

1 reference

Europe PubMed Central

19 September 2017

Kathryn C Zoon

6

1 reference

Europe PubMed Central

19 September 2017

Mario H Skiadopoulos

8

1 reference

Europe PubMed Central

19 September 2017

Emmalene J Bartlett

9

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

5 June 2006

1 reference

Europe PubMed Central

19 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

19 September 2017

352

1 reference

Europe PubMed Central

19 September 2017

1

1 reference

Europe PubMed Central

19 September 2017

61-73

1 reference

Europe PubMed Central

19 September 2017

The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Respiratory tract viral infections in inner-city asthmatic adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Human interferons alpha, beta and omega

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Inferences, questions and possibilities in Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Regulation of the Interferon System: Evidence that Vero Cells have a Genetic Defect in Interferon Production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Outbreak of pneumonia in a long-term care facility: antecedent human parainfluenza virus 1 infection may predispose to bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Are all type I human interferons equivalent?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Sendai virus C proteins must interact directly with cellular components to interfere with interferon action

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

A short peptide at the amino terminus of the Sendai virus C protein acts as an independent element that induces STAT1 instability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Paramyxovirus strategies for evading the interferon response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The interferon antiviral response: from viral invasion to evasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Synthesis of two distinct interferons by human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis Media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

A Longitudinal Study of Respiratory Viruses and Bacteria in the Etiology of Acute Otitis Media with Effusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Human type I interferons differ greatly in their effects on the proliferation of primary B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Differential responses to IFN-alpha subtypes in human T cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Thogoto virus ML protein suppresses IRF3 function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Inhibition of STAT 1 phosphorylation by human parainfluenza virus type 3 C protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Codon substitution mutations at two positions in the L polymerase protein of human parainfluenza virus type 1 yield viruses with a spectrum of attenuation in vivo and increased phenotypic stability in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Newcastle disease virus V protein is a determinant of host range restriction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The P genes of human parainfluenza virus type 1 clinical isolates are polycistronic and microheterogenous

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Antiviral actions of interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Triggering the interferon antiviral response through an IKK-related pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Sendai virus C protein physically associates with Stat1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Regulation of gene expression by cytokines and virus in human cells lacking the type‐I interferon locus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Inverse interference: how viruses fight the interferon system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

VISA is an adapter protein required for virus-triggered IFN-beta signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The anti-tumor activities of interferon (IFN)-alpha in chronic myelogenous leukaemia (CML)-derived cell lines depends on the IFN-alpha subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Downregulation of IRF-3 levels by ribozyme modulates the profile of IFNA subtypes expressed in infected human cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Mechanism by which the IFN-beta enhanceosome activates transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2006.04.011

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40272095&oldid=1826236304"